semaglutide naion use in patients with diabetes was associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) at 2, 3, and 4 years. https://ja.ma/4iZkMeV Semaglutide NAION Network Study Announcement

The amount discarded should be documented in the medical record and the J-code billed to reflect total units in the vial, with modifier JW distinguishing the administered portion from the discarded portion

Retrieved from Kanai, R., Kinoshita, S., Kanbe, I., et al

By stimulating natural growth hormone release, these therapies can support fat loss, lean muscle development, faster recovery, and even improvements in sleep quality and energy levels

This applies especially when using it for injections or medication preparation

While it may indirectly aid fat loss by supporting recovery and digestive function, theres limited direct clinical evidence linking BPC-157 to significant fat reduction